{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:37:39Z","timestamp":1773200259808,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["20180530102"],"award-info":[{"award-number":["20180530102"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.aohep.2021.100560","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T03:52:12Z","timestamp":1634183532000},"page":"100560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["IGF-1 alleviates CCL4-induced hepatic cirrhosis and dysfunction of intestinal barrier through inhibition TLR4\/NF-\u03baB signaling mediated by down-regulation HMGB1"],"prefix":"10.1016","volume":"26","author":[{"given":"Tianyu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2021.100560_bib0001","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(18)31659-3","article-title":"Liver cirrhosis","volume":"392","author":"Barnett","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.aohep.2021.100560_bib0002","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100560_bib0003","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.aohep.2021.100560_bib0004","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100560_bib0005","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat Protoc"},{"key":"10.1016\/j.aohep.2021.100560_bib0006","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awy131","article-title":"Wee Yong V. The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics","volume":"141","author":"Camara-Lemarroy","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.aohep.2021.100560_bib0007","first-page":"91","article-title":"Infections in patients affected by liver cirrhosis: an update","volume":"25","author":"Ascione","year":"2017","journal-title":"Le infezioni in medicina"},{"key":"10.1016\/j.aohep.2021.100560_bib0008","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"Journal of hepatology"},{"key":"10.1016\/j.aohep.2021.100560_bib0009","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/liv.12271","article-title":"Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature","volume":"33","author":"Pijls","year":"2013","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.aohep.2021.100560_bib0010","first-page":"353","article-title":"Gut microflora in the pathogenesis of the complications of cirrhosis. Best practice & research","volume":"18","author":"Garcia-Tsao","year":"2004","journal-title":"Clinical gastroenterology"},{"key":"10.1016\/j.aohep.2021.100560_bib0011","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.aohep.2021.100560_bib0012","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.molimm.2019.09.008","article-title":"Cucurbitacin E ameliorates lipopolysaccharide-evoked injury, inflammation and MUC5AC expression in bronchial epithelial cells by restraining the HMGB1-TLR4-NF-\u03baB signaling","volume":"114","author":"Shang","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.aohep.2021.100560_bib0013","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3389\/fimmu.2018.01979","article-title":"Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis","volume":"9","author":"Vicentino","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.aohep.2021.100560_bib0014","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1172\/JCI91786","article-title":"HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis","volume":"128","author":"Hernandez","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.aohep.2021.100560_bib0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJM199702273360907","article-title":"Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors","volume":"336","author":"Le Roith","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2021.100560_bib0016","first-page":"156","article-title":"[Insulin-like growth factor I (IGF-I) and liver cirrhosis]","volume":"99","author":"Conchillo","year":"2007","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.aohep.2021.100560_bib0017","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gut.2005.079988","article-title":"Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats","volume":"55","author":"Lorenzo-Z\u00fa\u00f1iga","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2021.100560_bib0018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12876-015-0311-5","article-title":"IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats","volume":"15","author":"Zhao","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.aohep.2021.100560_bib0019","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4110\/in.2011.11.4.223","article-title":"IGF-I Exerts an Anti-inflammatory Effect on Skeletal Muscle Cells through Down-regulation of TLR4 Signaling","volume":"11","author":"Lee","year":"2011","journal-title":"Immune Netw"},{"key":"10.1016\/j.aohep.2021.100560_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5213\/inj.2040430.215","article-title":"Protective Effect of Polydeoxyribonucleotide Against CCl4-Induced Acute Liver Injury in Mice","volume":"24","author":"Lee","year":"2020","journal-title":"Int Neurourol J"},{"key":"10.1016\/j.aohep.2021.100560_bib0021","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2131\/jts.41.561","article-title":"Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis","volume":"41","author":"Dong","year":"2016","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.aohep.2021.100560_bib0022","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/jdi.13000","article-title":"Insulin-like growth factor-1 is inversely associated with liver fibrotic markers in patients with type 2 diabetes mellitus","volume":"10","author":"Miyauchi","year":"2019","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.aohep.2021.100560_bib0023","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41419-019-1670-6","article-title":"Insulin-like growth factor-1 attenuates oxidative stress-induced hepatocyte premature senescence in liver fibrogenesis via regulating nuclear p53-progerin interaction","volume":"10","author":"Luo","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.aohep.2021.100560_bib0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-0043-118911","article-title":"Impairment of GH\/IGF-1 Axis in the Liver of Patients with HCV-Related Chronic Hepatitis","volume":"50","author":"Carotti","year":"2018","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.aohep.2021.100560_bib0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/10520295.2012.758311","article-title":"Serum IGF-1 levels correlate negatively to liver damage in diabetic rats","volume":"88","author":"Aksu","year":"2013","journal-title":"Biotech Histochem"},{"key":"10.1016\/j.aohep.2021.100560_bib0026","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/abbs\/gms059","article-title":"IGF-1 alleviates ox-LDL-induced inflammation via reducing HMGB1 release in HAECs","volume":"44","author":"Yu","year":"2012","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.aohep.2021.100560_bib0027","first-page":"4711","article-title":"Insulin-like growth factor I reduces the occurrence of necrotizing enterocolitis by reducing inflammatory response and protecting intestinal mucosal barrier in neonatal rats model","volume":"21","author":"Tian","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.aohep.2021.100560_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5928078","article-title":"HMGB1 and Extracellular Histones Significantly Contribute to Systemic Inflammation and Multiple Organ Failure in Acute Liver Failure","volume":"2017","author":"Yang","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.aohep.2021.100560_bib0029","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1089\/dna.2019.5330","article-title":"HMGB1 Inhibits HNF1A to Modulate Liver Fibrogenesis via p65\/miR-146b Signaling","volume":"39","author":"Ge","year":"2020","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.aohep.2021.100560_bib0030","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1038\/s41598-017-07094-y","article-title":"Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2021.100560_bib0031","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2119\/2006-00010.Yang","article-title":"Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock","volume":"12","author":"Yang","year":"2006","journal-title":"Mol Med"},{"key":"10.1016\/j.aohep.2021.100560_bib0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2017.12.008","article-title":"The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4\/NF-\u03baB and PI3K\/Akt\/mTOR pathways","volume":"94","author":"Meng","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1016\/j.aohep.2021.100560_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117120","article-title":"HMGB1 was negatively regulated by HSF1 and mediated the TLR4\/MyD88\/NF-\u03baB signal pathway in asthma","volume":"241","author":"Shang","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.aohep.2021.100560_bib0034","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/gast.2002.35391","article-title":"HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice","volume":"123","author":"Sappington","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100560_bib0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00011-019-01251-x","article-title":"High-mobility group box-1 inhibition stabilizes intestinal permeability through tight junctions in experimental acute necrotizing pancreatitis","volume":"68","author":"Huang","year":"2019","journal-title":"Inflamm Res"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268121002593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268121002593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:44:36Z","timestamp":1761648276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268121002593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"alternative-id":["S1665268121002593"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2021.100560","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGF-1 alleviates CCL4-induced hepatic cirrhosis and dysfunction of intestinal barrier through inhibition TLR4\/NF-\u03baB signaling mediated by down-regulation HMGB1","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2021.100560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100560"}}